Ovarian cancer fall sped up as hormone use dropped

By Kathryn Doyle NEW YORK (Reuters Health) – Ovarian cancer rates in the U.S. began to decline faster in 2002 around the time many older women went off hormone replacement therapy, according to a new study. That year, the Women’s Health Initiative (WHI) found that estrogen or estrogen plus progestin hormone therapy, prescribed for the symptoms of menopause, was linked to an increased risk of breast cancer, stroke and heart attack. …